Cormorant Asset Management

Cormorant Asset Management is a Boston-based investment manager with investment focus in both public and private market innovative companies in the biotechnology and life sciences marketplace.

Cormorant Asset Management is a Boston-based investment manager with investment focus in both public and private market innovative companies in the biotechnology and life sciences marketplace.

See All Exits Recent Exits

Phone:

Fax:



Boston,
Massachusetts, United States

Cormorant Asset Management - Investments & Acquisitions

Show Real Data Cormorant Asset Management Investments
See all Recent Investments
Date Company Round Amount Co-investors
2021-05-26NiKang TherapeuticsSeries C$200MAlly Bridge Group, BlackRock, Casdin Capital, CBC Group, EcoR1 Capital, HBM Healthcare Investments, Invus Group, Janus Henderson Investors, Lilly Asia Ventures, Logos Capital, Matrix Partners China, Octagon Capital, Pavilion Capital, Perceptive Advisors, PFM Health Sciences, RA Capital Management, RTW Investments, Samsara BioCapital, Surveyor Capital, and Wellington Management
2021-05-20BiVACORSeries B$19MOneVentures
2021-05-20Numab TherapeuticsSeries C$111MBlackRock, BVF Partners, Forbion Capital Partners, HBM Partners, Novo Ventures, Octagon Capital, and RTW Investments
2021-05-18Interius BioTherapeuticsSeries A$76MAgent Capital, American Cancer Society, Bain Capital Ventures, BrightEdge, Fairmount Funds Management, Knollwood Investment Advisory, Logos Capital, Longwood Fund, Mark Foundation for Cancer Research, Osage University Partners, Penn Medicine, Pfizer Venture Investments, Quan Capital, RA Capital Management, Tellus BioVentures, and University of Pennsylvania
2021-05-13Elpiscience BiopharmaceuticalsSeries C$105MCITIC securities Investment, Greater Bay Area Homeland Investments, Maison Capital, Qian Dao Fund, and Superstring Capital
See all 5 investments